Stroke prevention clinical trials
31 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- The TAIL-PrEP Study
- Suubi4PrEP: Improving PrEP Access and Adherence Among Adolescent Girls and Young Women in Uganda
- WePrEP: Developing a PrEP Shared Decision-making Tool for Transgender Women
- Optimizing PrEP Uptake and Adherence Among Male Sex Workers
- Streamlining Telehealth for Expanded PrEP Utilization Through Community Partnerships
- Behavioral Economic Intervention to Improve HIV Behaviors in Sexual Minority Individuals
- Intervention to Enhance PrEP Persistence
- Safety Study of MucoCept-CVN
- Evaluating an Interactive Digital Toolkit for Women's PrEP Implementation
- Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP
- Prepping for The Talk: Helping Trusted Adults and Youth Talk About Sexual Health
- Using PrEP, Doing It for Ourselves
- Mobile Vehicle-Based Delivery of Lenacapavir Pre-Exposure Prophylaxis in Los Angeles County
- The Unlocking PrEP Study: Integration of Peer Health Navigation Into Comprehensive Re-entry Services
- PEP/PrEP Via Pharmacist-Prescribing Implementation (PEPPI)
- Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention
- Enhancing Wellness Through Affirming Services and Education
- Evaluating the Safety and Immunogenicity of Polyvalent DNA and Recombinant gp120 Protein HIV Vaccine (PDPHV) in Healthy, HIV-uninfected Adults
- Examining Migration, Social Bonds, Transnationalism, and HIV Prevention Pathways Among African Immigrants.
- Leveraging Video Logs as a Bridge to Pre-exposure Prophylaxis (PrEP) With Tailored Messaging to Black Women and Their Healthcare Providers in Texas.
- Initiative for Chinese Sex Workers to Promote Wellbeing and Improve HIV Prevention by Reducing intersEctional Stigma
- Are Louisiana Pharmacists PrEPared? Implementing Training and an Active PrEP (Pre-Exposure Prophylaxis) Prescribing Surveillance Program
- PrEP4U: Assessing the Effectiveness of Integrated Same-Day Lenacapavir Initiation and Follow-up Choice on PrEP Persistence
- A Social Network Approach to Improve HIV Prevention and Substance Use Treatment For People Who Use Drugs
- Integrating Supports to Promote PrEP for Black Adolescents Working With Apps- Alabama
- Client-Centered Care Coordination for Black Men Who Have Sex With Men
- A Self-administered PrEP Decisional Aid for Dissemination With HIV Self-test Kits (DASH)
- The PROTECT (PrEP Optimization Through Telehealth Care and Treatment) Trial
- Adaptive Intervention Strategies for HIV PrEP Care in Rural People Who Inject Drugs
- A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIV
- Hybrid Evaluation of a Home-based HIV Pre-exposure Prophylaxis Program
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Stroke prevention” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.